BidaskClub cut shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) from a buy rating to a hold rating in a research report report published on Wednesday, July 19th.
A number of other equities analysts have also commented on the stock. Zacks Investment Research raised shares of DENTSPLY SIRONA from a hold rating to a buy rating and set a $72.00 price target on the stock in a research report on Thursday, July 13th. Credit Suisse Group reissued an outperform rating and issued a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a buy rating and a $74.00 price target on the stock. Cleveland Research raised shares of DENTSPLY SIRONA from a neutral rating to a buy rating in a research report on Tuesday, May 23rd. Finally, Goldman Sachs Group, Inc. (The) lowered shares of DENTSPLY SIRONA from a neutral rating to a sell rating and dropped their price target for the company from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $67.92.
Shares of DENTSPLY SIRONA (NASDAQ XRAY) traded down 0.41% on Wednesday, hitting $62.65. 1,033,082 shares of the stock traded hands. DENTSPLY SIRONA has a 12-month low of $55.00 and a 12-month high of $65.68. The stock has a 50-day moving average price of $63.96 and a 200 day moving average price of $62.13. The stock has a market cap of $14.36 billion, a price-to-earnings ratio of 40.32 and a beta of 1.27.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by $0.01. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The business had revenue of $900.50 million for the quarter, compared to the consensus estimate of $916.55 million. During the same period in the previous year, the business posted $0.69 EPS. DENTSPLY SIRONA’s revenue was up 16.6% compared to the same quarter last year. On average, analysts anticipate that DENTSPLY SIRONA will post $2.84 earnings per share for the current fiscal year.
WARNING: “DENTSPLY SIRONA Inc. (XRAY) Stock Rating Lowered by BidaskClub” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://stocknewstimes.com/2017/07/31/dentsply-sirona-inc-xray-stock-rating-lowered-by-bidaskclub-updated.html.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 22.58%.
A number of institutional investors have recently made changes to their positions in XRAY. First National Bank of Omaha raised its position in shares of DENTSPLY SIRONA by 1.6% in the first quarter. First National Bank of Omaha now owns 144,523 shares of the medical instruments supplier’s stock worth $9,024,000 after buying an additional 2,318 shares during the period. National Pension Service raised its position in shares of DENTSPLY SIRONA by 37,487.7% in the first quarter. National Pension Service now owns 201,846 shares of the medical instruments supplier’s stock worth $12,646,000 after buying an additional 201,309 shares during the period. Gulf International Bank UK Ltd raised its position in shares of DENTSPLY SIRONA by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 74,565 shares of the medical instruments supplier’s stock worth $4,655,000 after buying an additional 1,000 shares during the period. Creative Planning raised its position in shares of DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock worth $425,000 after buying an additional 70 shares during the period. Finally, S&CO Inc. increased its stake in DENTSPLY SIRONA by 110.6% in the first quarter. S&CO Inc. now owns 7,674 shares of the medical instruments supplier’s stock worth $479,000 after buying an additional 4,030 shares in the last quarter. 94.92% of the stock is currently owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
